BSECompany Update10 Aug 2026 · 10 Aug 2026, 07:00 pm
Please find attached.
Alembic Pharmaceuticals Ltd · 533573
✦ AI SummaryMgmt Change
Alembic Pharmaceuticals Ltd has announced the resignation of Ms. Manisha Saraf as Company Secretary & Compliance Officer, effective August 10, 2026.
Analysis Scores
Earnings Impact2/10
Growth Catalyst1/10
Governance Concern2/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
Attachments (1)
📄pdf
Download →
47145270-a2ac-4e2a-82e9-c40b78022f77.pdf
View document text
Date: 10th August, 2026
To, To,
The Manager, The Manager,
Department of Corporate Services, Listing Department,
BSE Limited National Stock Exchange of India Ltd.
P. J. Towers, Dalal Street, ‘Exchange Plaza’, Bandra Kurla Complex,
Fort, Mumbai – 400 001 Bandra (E), Mumbai – 400 051
Scrip Code:533573 NSE Symbol: APLLTD
Dear Sir / Madam,
Sub: Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 – Change in Management.
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, we would like to inform the exchange that Ms. Manisha Saraf, Company
Secretary & Compliance Officer (Membership No. A20998) has resigned from the position of
Company Secretary & Compliance Officer (Key Managerial Personnel) and Nodal Officer of
the Company w.e.f. 10th August, 2026 (close of business hours).
The details as required under the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 read with SEBI Master Circular No. HO/49/14/14(7)2025-CFD-
POD2/I/3762/2026 dated 30th January, 2026, along with her resignation letter are enclosed as
Annexure – A & Annexure – B respectively.
We request you to kindly take the same on record.
Thanking you,
Yours faithfully,
For Alembic Pharmaceuticals Limited
G. Krishnan
Chief Financial Officer
Encl: A/a
ALEMBIC PHARMACEUTICALS LIMITED
REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229
Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123
Annexure – A
Details under Regulation 30 of the SEBI (Listing Obligations and Disclosure
Requirements) Regulations, 2015 read with SEBI Master Circular No.
HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated 30th January 2026:
Sr. Particulars Details of change - Ms. Manisha Saraf
1. Reason for change Resignation
2. Date of cessation w.e.f. 10th August, 2026 (close of business hours)
3. Brief profile (in case of Not Applicable
appointment)
4. Disclosure of Not Applicable
relationships between
directors
ALEMBIC PHARMACEUTICALS LIMITED
REGD. OFFICE: ALEMBIC ROAD, VADODARA - 390 003. ● TEL: (0265) 2280550, 2280880 ● FAX: (0265) 2281229
Website : www.alembicpharmaceuticals.com ● E-mail : alembic@alembic.co.in ● CIN : L24230GJ2010PLC061123
Annexure - B
Date: 4th June, 2026
The Board of Directors
Alembic Pharmaceuticals Limited
Alembic Road, Vadodara -390003
Dear Sir/ Madam,
Sub: Resignation form the Post of Company Secretary, Compliance Officer and Nodal
Officer of the Company
I hereby formally tender my resignation as Company Secretary & Compliance Officer, Key
Managerial Personnel and all other statutory/ designated position of the Company to pursue a
new opportunity that is better aligned with my long-term career aspirations and offers avenues
for further growth and development.
I would like to take this opportunity to place on record my gratitude to the members of the Board,
my colleagues and other stakeholders with whom I had the opportunity to work during my tenure,
and I wish the Company every success in its future endeavours.
I request to relieve me from my responsibilities effective closing of business hours on 10th August,
2026.
Kindly acknowledge receipt of this resignation and take the necessary actions to give effect to it,
including filing the required forms with the Registrar of Companies, Ministry of Corporate Affairs
and intimating the stock exchanges.
Thanking You
Yours Sincerely
�Saraf
ECSIN:EA020998E000000109
M.No. A20998